These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2387525)

  • 1. Sucralfate, bismuth subcitrate, and gastric HCO3 in humans.
    Guslandi M
    Gut; 1990 Aug; 31(8):958-9. PubMed ID: 2387525
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of bismuth subcitrate and sucralfate on rat duodenal and human gastric bicarbonate secretion in vivo.
    Shorrock CJ; Garner A; Hunter AH; Crampton JR; Rees WD
    Gut; 1990 Jan; 31(1):26-31. PubMed ID: 2318428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of bismuth subcitrate on amphibian gastroduodenal bicarbonate secretion.
    Shorrock CJ; Crampton JR; Gibbons LC; Rees WD
    Gut; 1989 Jul; 30(7):917-21. PubMed ID: 2788112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of certain ulcer-healing agents on amphibian gastroduodenal bicarbonate secretion.
    Crampton JR; Gibbons LC; Rees WD
    Scand J Gastroenterol Suppl; 1986; 125():113-8. PubMed ID: 3493520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the understanding of the mechanism of cytoprotective action by colloidal bismuth subcitrate.
    Konturek SJ; Radecki T; Piastucki I; Drozdowicz D
    Scand J Gastroenterol Suppl; 1986; 122():6-10. PubMed ID: 3465028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of protective drugs on gastric alkaline secretion in man.
    Konturek SJ; Kwiecien N; Obtulowicz W; Hebzda Z; Oleksy J
    Scand J Gastroenterol; 1987 Nov; 22(9):1059-63. PubMed ID: 3423732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric mucosa protective effects of colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Int J Tissue React; 1987; 9(5):427-32. PubMed ID: 3478321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric mucosa protection and prostaglandin E2 generation in rats by colloidal bismuth subcitrate (DE-NOL).
    Hall DW; van den Hoven WE
    Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):308-19. PubMed ID: 3473983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate.
    Copeman M; Matuz J; Leonard AJ; Pearson JP; Dettmar PW; Allen A
    J Gastroenterol Hepatol; 1994; 9 Suppl 1():S55-9. PubMed ID: 7881020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colloidal bismuth subcitrate evokes adaptive cytoprotection in rat gastric mucosa.
    Balint GA
    Acta Med Hung; 1991; 48(3-4):197-201. PubMed ID: 1822857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of putative cytoprotective properties of antiulcer drugs using quantitative histological techniques.
    O'Brien PE; Frydman G; Holmes R; Malcontenti C; Phelan D
    Dig Dis Sci; 1990 Sep; 35(9):1130-9. PubMed ID: 2390928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of cytoprotective agents in the treatment of gastric ulcers.
    Lam SK
    Med J Aust; 1985 Feb; 142 Spec No():S21-3. PubMed ID: 3841578
    [No Abstract]   [Full Text] [Related]  

  • 13. De-Nol stimulates gastric and duodenal alkaline secretion through prostaglandin dependent mechanism.
    Konturek SJ; Bilski J; Kwiecien N; Obtuløwicz W; Kopp B; Oleksy J
    Gut; 1987 Dec; 28(12):1557-63. PubMed ID: 3480844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The minimum inhibitory concentrations of various bismuth salts against Campylobacter pylori.
    Vogt K; Warrelmann M; Hahn H
    Zentralbl Bakteriol; 1989 Sep; 271(3):304-10. PubMed ID: 2803458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of nonantisecretory agents.
    De Wal J
    Dig Dis Sci; 1988 Oct; 33(10):1342. PubMed ID: 3168705
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement in gastric mucus gel qualities with colloidal bismuth subcitrate administration.
    Piotrowski J; Bilski J; Nishikawa H; Slomiany A; Slomiany BL
    Eur J Pharmacol; 1990 Aug; 184(1):55-63. PubMed ID: 2209715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New therapeutic approaches to peptic ulcer using mucosal protective agents].
    Jin M; Otaka M; Watanabe S
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():377-81. PubMed ID: 11979810
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ulcer therapy without acid inhibition].
    Koelz HR
    Schweiz Med Wochenschr; 1984 May; 114(20):686-93. PubMed ID: 6547542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphology of the gastric mucosa in patients with duodenal ulcer treated with bismuth-containing drugs].
    Mach T
    Folia Med Cracov; 1995; 36(1-4):53-75. PubMed ID: 8834668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of sucralfate and bismuth subsalicylate in simulated gastric fluid.
    Kappstein I; Engels I
    Eur J Clin Microbiol; 1987 Apr; 6(2):216-7. PubMed ID: 3595590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.